As noted by Manasyan et al., while these agents reduce insulin requirements and maintain adequate glucose control with fewer hypoglycemic events, they may simultaneously impede adequate nutrition as a result of delayed gastric emptying and present a risk of aspiration
Factors such as temperature, pH, oxygen, light, and metal ions can significantly accelerate this oxidation process
For patients with type 2 diabetes , the American Diabetes Association recommends individualized glycemic targets and regular reassessment of pharmacologic therapy
Research findings indicate that Epigallocatechin-3-gallate (EGCG) has the capacity to decrease the levels of inducible Nitric Oxide Synthase (iNOS) and nitric oxide metabolites (NOx), as well as reactive oxygen species (ROS) in lung tissue
Medical organizations including the American College of Obstetricians and Gynecologists acknowledge that some GLP-1 drugs may be compatible with lactation on a case-by-case basis, but semaglutide specifically lacks sufficient human data for confident reassurance